Thomas A Waldmann, M.D.

Rare Disease / Clinical Research

National Cancer Institute (NCI)

PI on 6 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Large granular lymphocyte leukemia
Adult T-cell leukemia/lymphoma
Refractory celiac disease
T-cell large granular lymphocyte leukemia
Acquired cystic disease-associated renal cell carcinoma
Chronic lymphoproliferative disorder of natural killer cells
Aggressive NK-cell leukemia

Clinical trials (6)

NCT00076180
NCT01021059
NCT00117845
NCT00061048
NCT01893775
NCT00005655

Verify independently

ClinicalTrials.gov PI search for Thomas A Waldmann, M.D.

Other specialists for Large granular lymphocyte leukemia

Peers ranked by clinical-trial PI role, publications, and verification quality.

Brenda Sandmaier
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
WA
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Ryotaro Nakamura
City of Hope Medical Center
California
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
Elizabeth Fox, MD
National Cancer Institute (NCI)
Nancy Wells, DNSc, RN
Vanderbilt-Ingram Cancer Center
George Chen
Roswell Park Cancer Institute
Yasuhiro Oki, M.D
M.D. Anderson Cancer Center
TX

See all specialists for Large granular lymphocyte leukemia →

← Back to specialists directory